Cargando…
Target versus non-target lesions in determining disease progression: analysis of 545 patients
Autores principales: | Raskin, S, Klang, E, Amitai, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601547/ http://dx.doi.org/10.1186/1470-7330-15-S1-S8 |
Ejemplares similares
-
Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy
por: Harris, AL
Publicado: (2000) -
Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
por: Radtke, JP, et al.
Publicado: (2015) -
Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function
por: Thakur, Ram Krishna, et al.
Publicado: (2014) -
Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma
por: Dresen, R, et al.
Publicado: (2015) -
Evolution of resistance to MAPK-targeted therapies
por: Lo, Roger
Publicado: (2015)